Registro:

Referencias:

• Tokunaga, T., Yamamoto, H., Shimada, S., Abe, H., Fukuda, T., Fujisawa, Y., Furutani, Y., Sudo, T., Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity (1984) J. Natl. Cancer Inst., 72, pp. 955-962
• Yamamoto, S., Yamamoto, T., Shimada, S., Kuramoto, E., Yano, O., Kataoka, T., Tokunaga, T., DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth (1992) Microbiol. Immunol., 36, pp. 983-997
• Kuramoto, E., Yano, O., Kimura, Y., Baba, M., Makino, T., Yamamoto, S., Yamamoto, T., Tokunaga, T., Oligonucleotide sequences required for natural killer cell activation (1992) Jpn. J. Cancer Res., 83, pp. 1128-1131
• Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M.D., Silverman, G.J., Raz, E., Immunostimulatory DNA sequences necessary for effective intradermal gene immunization (1996) Science, 273, pp. 352-354
• Krieg, A.M., Yi, A.K., Matson, S., Waldschmidt, T.J., Bishop, G.A., Teasdale, R., Koretzky, G.A., Klinman, D.M., CpG motifs in bacterial DNA trigger direct B-cell activation (1995) Nature, 374, pp. 6546-6549
• Stacey, K.J., Sweet, M.J., Hume, D.A., Macrophages ingest and are activated by bacterial DNA (1996) J. Immunol., 157, pp. 2116-2122
• Jakob, T., Walker, P.S., Krieg, A.M., Udey, M.C., Vogel, J.C., Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA (1998) J. Immunol., 161, pp. 3042-3049
• Sparwasser, T., Koch, E.S., Vabulas, R.M., Heeg, K., Lipford, G.B., Ellwart, J.W., Wagner, H., Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells (1998) Eur. J. Immunol., 28, pp. 2045-2054
• Ballas, Z.K., Rasmussen, W.L., Krieg, A.M., Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA (1996) J. Immunol., 157, pp. 1840-1845
• Cowdery, J.S., Chace, J.H., Yi, A.K., Krieg, A.M., Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysaccharides (1996) J. Immunol., 156, pp. 4570-4575
• Stan, A.C., Casares, S., Brumeanu, T.D., Klinman, D.M., Bona, C.A., CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes (2001) Eur. J. Immunol., 31, pp. 301-310
• Klinman, D.M., Barnhart, K.M., Conover, J., CpG motifs as immune adjuvants (1999) Vaccine, 17, pp. 19-25
• Klinman, D.M., Yamshchikov, G., Ishigatsubo, Y., Contribution of CpG motifs to the immunogenicity of DNA vaccines (1997) J. Immunol., 158, pp. 3635-3639
• Biswas, S., Ashok, M.S., Reddy, G.S., Srinivasan, V.A., Rangarajan, P.N., Evaluation of the protective efficacy of rabies DNA vaccine in mice using an intracerebral challenge model (1999) Curr. Sci., 76, pp. 1012-1016
• Vinner, L., Nielsen, H.V., Bryder, K., Corbet, S., Nielsen, C., Fomsgaard, A., Gene gun DNA vaccination with Revindependent synthetic HIV-1 gp160 envelope gene using mammalian codons (1999) Vaccine, 17, pp. 2166-2175
• Tighe, H., Corr, M., Roman, M., Raz, E., Gene vaccination: Plasmid DNA is more than just a blueprint (1998) Immunol. Today, 19, pp. 89-97
• Krieg, A.M., Yi, A.K., Schorr, J., Davis, H.L., The role of CpG dinucleotides in DNA vaccines (1998) Trends Microbiol., 6, pp. 23-27
• Thalhamer, J., Leitner, W., Hammerl, P., Brtko, J., Designing immune responses with genetic immunization and immunostimulatory DNA sequences (2001) Endocr. Regul., 35, pp. 143-166
• Kadowaki, N., Ho, S., Antonenko, S., de Waal, M.R., Kastelein, R.A., Bazan, F., Liu, Y.J., Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens (2001) J. Exp. Med., 194, pp. 863-870
• Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdorfer, B., Giese, T., Endres, S., Hartmann, G., Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides (2002) J. Immunol., 168, pp. 4531-4537
• Shoda, L.K., Kegerreis, K.A., Suarez, C.E., Mwangi, W., Knowles, D.P., Brown, W.C., Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-alpha, and NO production by bovine macrophages (2001) J. Leukoc. Biol., 70, pp. 103-112
• Krieg, A.M., Wu, T., Weeratna, R., Efler, S.M., Love-Homan, L., Yang, L., Yi, A.K., Davis, H.L., Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs (1998) Proc. Natl. Acad. Sci. USA, 95, pp. 12631-12636
• Kojima, Y., Xin, K.Q., Ooki, T., Hamajima, K., Oikawa, T., Shinoda, K., Ozaki, T., Okuda, K., Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine (2002) Vaccine, 20, pp. 2857-2865
• Nicklin, P.S., Craig, S.J., Phillips, J.A., Pharmacokinetic properties of phosphorothioates in animals-absorption, distribution, metabolism and elimination (1998) Antisense Research and Application, 4, pp. 141-168. , Agrawal, S. and Crooke, S. T. (Eds.) Springer, Berlin
• Yi, A.K., Tuetken, R., Redford, T., Waldschmidt, M., Kirsch, J., Krieg, A.M., CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species (1998) Immunology, 160, pp. 4755-4761
• Hacker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., Sparwasser, T., Heeg, K., Wagner, H., CpG-DNAspecific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation (1998) EMBO J., 17, pp. 6230-6240
• Fló, J., Perez, A.B., Tisminetzky, S., Baralle, F., Superiority of intramuscular route and full length glycoprotein D for DNA vaccination against herpes simplex-2. Enhancement of protection by the co-delivery of the GM-CSF gene (2000) Vaccine, 18, pp. 3242-3253
• Fló, J., Tisminetzky, S., Baralle, F., Codelivery of costimulatory molecules induces in a route dependent manner up or down regulation of the immune response against herpes simplex virus 2 in DNA vaccine (2000) Immunology, 100, pp. 259-267

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------